This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
An investigational anti-VEGF biologic designed to deliver immediate and durable disease control
An investigational, high-strength, bispecific protein designed to treat macular edema secondary to inflammation (MESI), for which no approved intravitreal biologic exists today
An investigational anti-IL-6 and VEGF trap bispecific biologic designed for higher efficacy and higher durability